Sagent Pharmaceuticals, Inc. and Itochu Chemical Frontier Corporation Announce Development and Manufacturing Collaboration

Friday, October 10, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

SCHAUMBURG, Ill., Oct. 9 Sagent Pharmaceuticals, Inc., aprivately-held specialty pharmaceutical company, and Itochu Chemical FrontierCorporation (ICF), a privately-held global company in the field ofpharmaceutical and organic and fine chemicals based in Japan, today announcedfinalization of a development and supply collaboration. Under the agreement,ICF will supply injectable products for which Sagent will obtain U.S.regulatory approval and market in the United States.

"We are extremely pleased to partner with a global company of Itochu'scaliber and skills on these exciting product opportunities," said Jeffrey M.Yordon, CEO, founder and chairman of the board of Sagent Pharmaceuticals, Inc."Sagent is committed to expanding its network of worldwide strategicpartnerships to offer the most diverse and extensive pipeline of the highestquality injectable products to our hospital focused customers and we lookforward to including ICF amongst our partners."

"ICF looks forward to rapidly expanding our presence in the U.S. market,"said Jun Sato, ICF's president and chief executive officer. "We believe thatthis collaboration combining ICF's experience in the Japanese market withSagent's U.S. focused injectable selling and marketing capabilities is anoptimal path toward achieving this objective."

About Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals, founded in 2006, is a privately held specialtypharmaceutical company focused on developing, manufacturing, sourcing andmarketing pharmaceutical products, with a specific emphasis on injectableproducts. Sagent has created a unique, global network of resources, comprisedof rapid development capabilities, sophisticated manufacturing and innovativedrug-delivery technologies, quickly yielding an extensive portfolio ofpharmaceutical products that fulfills the evolving needs of patients. Sagentcurrently has more than 200 products in development.

To Discover Injectables Excellence(TM) and learn more about Sagent, pleasevisit http://www.SagentPharma.com.

About Itochu Chemical Frontier Corporation

Itochu Chemical Frontier Corporation (ICF) is the core enterprise ofPharmaceutical & Life-science and Organic & Fine Chemical field in ITOCHUCorporation which is one of the largest trading houses in the world.Pharmaceutical division of ICF has a global net work of resources for ActivePharmaceutical Ingredient (API) and Pharmaceutical Finished Products in theextensive pipeline from primary care to high potency pharmaceuticals such asantibiotic, anticancer and biologic products and supplies them to ourworldwide business partners.

To learn more about Itochu Chemical Frontier, please visithttp://www.itcchem.co.jp/en/index.html

SOURCE Sagent Pharmaceuticals, Inc.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook